Glycosylated Hemoglobin and C-Peptide Market
Global Glycosylated Hemoglobin And C Peptide Market Size, Share & Trends Analysis Report By Product (Tablet, Capsules, Injectable, and Others), By Application (Oncology, Blood Disorder, Diabetes, and Other) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global glycosylated hemoglobin and c peptide market is anticipated to grow at a considerable CAGR during the forecast period. Glycosylated hemoglobin is used to evaluate the recent blood glucose level in patients who are suffering from diabetes. It is not used to measure the fluctuation of blood glucose in patients. An increase in the blood glucose level of people who have diabetes is directly related to the decline of islet function. In the case of type 1 diabetes, the fluctuation in blood glucose level can be seen by the GA/HBA1C ratio and it is considered much more convenient than MAGE. For patients who have a low C peptide level, their GA/HBA1 C ratio is high than those patients who have their C peptide level high. The factors such as increasing incidences of cancers, diabetes, and other blood disorders due to changing lifestyles of the people, are driving the market growth. Increasing patients visits in hospitals suffering from diabetes, and other blood disorders increasing the significant scope for the market growth. As per the Diabetes UK, it is expected that 5.5 million people will have diabetes in the UK by 2030. 850,000 people are currently living with type 2 diabetes but are yet to be diagnosed.
Impact of COVID-19 Pandemic on Global Glycosylated hemoglobin and c peptide Market
The COVID-19 pandemic had positive impact on glycosylated hemoglobin and c peptide market. Underlying diabetes mellitus and cardiovascular diseases are considered risk factors for increased coronavirus disease. During the COVID-19 pandemic, tight control of glucose levels and prevention of diabetes complications might be crucial in patients with diabetes mellitus to keep susceptibility low and to prevent severe courses of COVID-19. Due to all these, there were high demand for glycosylated hemoglobin and c peptides.
Segmental Outlook
The global glycosylated hemoglobin and c peptide market is segmented based on product and application. Based on product, the market is segmented into a tablet, capsules, injectable, and others. Based on application the market is sub-segmented into oncology, blood disorder, diabetes, and others. Among these, the diabetes segment is projected to show fastest growth in the market during the forecast period.
Tablet is Anticipated to Hold a Prominent Share in the Global Glycosylated hemoglobin and c peptide Market
Tablet is anticipated to hold a prominent market share in the global glycosylated hemoglobin and c peptide market during the forecast period. This segment is anticipated to rise during the forecast period as people are kept on a medical dose for keeping their insulin level normal. For this, an efficient and easy method is to keep them on oral medication which is in form of tablets. Studies have the effective signs of tablets in patients with diabetes. For instance, in Aug 2021, according to a study published in the New England journal of medicine, patients who have type 2 diabetes tirzepatide was found efficient during a 40-week trial.
Regional Outlooks
The global glycosylated hemoglobin and c peptide market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). North America is anticipated to lead the glycosylated hemoglobin and c peptide market during the forecast period. Whereas Asia-Pacific is expected to be the fastest growing during the forecast period. The major factors such as increasing geriatric population and rising demand for advanced glycosylated hemoglobin and C-peptide tests for blood sugar monitoring are boosting the market growth.
Global Glycosylated hemoglobin and c peptide Market Growth, by Region 2022-2028
North America is Estimated to Hold the Major Share in the Global Glycosylated hemoglobin and c peptide Market
Geographically, it is anticipated that the major share of the market will be taken by North America and this region will lead during the forecast period. An increase in cases of diabetes is a major reason for this market to grow during the forecast period. According to CDC, in 2021 around 34.2 million adults have diabetes in the US. For instance, in Feb 2022, according to a study published in Diabetologia diet which is low in carbs and are high in protein improves glycated hemoglobin in patients who have type 2 diabetes.
Market Players Outlook
The major companies serving the global glycosylated hemoglobin and c peptide market include Pfizer Inc., Medtronic, F.Hoffmann-La Roche Ltd., Sandoz International GmBh, Biocon Ltd., and others. The market players are adopting different market strategies such as mergers and acquisitions, new product launches, business expansion, partnership collaboration, and others. For instance, in Jan 2021, in a study published in the New England journal of medicine for patients who suffered from heart failure and diabetes, sotagliflozin therapy was found to be effective and resulted in lower deaths.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Glycosylated hemoglobin and c peptide market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Glycosylated hemoglobin and c peptides Market
• Recovery Scenario of Global Glycosylated hemoglobin and c peptides Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Pfizer Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Medtronic Plc
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. F.Hoffmann-La Roche Ltd
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Sandoz International GmbH
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Biocon Ltd.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Glycosylated hemoglobin and c peptides Market by Product
4.1.1. Tablet
4.1.2. Capsules
4.1.3. Injectable
4.1.4. Others
4.2. Global Glycosylated hemoglobin and c peptides Market by Application
4.2.1. Oncology
4.2.2. Blood disorder
4.2.3. Diabetes
4.2.4. Other
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Novartis AG
6.2. Sanofi SA
6.3. Dr Reddy’s Laboratories Ltd.
6.4. Celltrion Healthcare Co. Ltd.
6.5. Medtronic PLC
6.6. Lee BioSolution
6.7. Portea Medical
1. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
2. GLOBAL TABLET IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL CAPSULES IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL INJECTABLE IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL OTHER GLYCOSYLATED HEMOGLOBIN AND C PEPTIDES PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN BLOOD DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
14. NORTH AMERICAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
15. EUROPEAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
17. EUROPEAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS PRODUCT, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
23. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET, 2021-2027 (%)
4. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
5. GLOBAL TABLET IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL CAPSULES IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL INJECTABLE IN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL OTHER GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE PRODUCT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN ONCOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN BLOOD DISORDER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN DIABETES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE IN OTHER APPLICATIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. US GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
17. UK GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
26. SOUTH KOREA GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF ASIA-PACIFIC GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF THE WORLD GLYCOSYLATED HEMOGLOBIN AND C PEPTIDE MARKET SIZE, 2021-2028 ($ MILLION)
